Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP)
Lake Erie Medical DBA Quality Care Products LLC
ORAL
PRESCRIPTION DRUG
Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. Terbinafine tablets are contraindicated in patients with: - History of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see Adverse Reactions (6.2)] - Chronic or active liver disease [see Warnings and Precautions (5.1)] Pregnancy Category B There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, and because treatment of onychomycosis can be postponed until after pregnancy is completed, it is recommended that terbinafine tablets not be initiated during pregnancy. Oral reproduction studies have been performed in rabbits and rats at doses up to 3
Terbinafine Tablets USP, 250 mg are supplied as white to off-white, round uncoated, biconvex beveled edge tablets having ‘D’ debossed on one side and ‘74’ on the other side. 55700-344-60 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light.
Abbreviated New Drug Application
TERBINAFINE- TERBINAFINE HYDROCHLORIDE TABLET Lake Erie Medical DBA Quality Care Products LLC ---------- MEDICATION GUIDE Terbinafine Tablets, USP [Terbinafine (ter BIN na feen)] What is the most important information I should know about terbinafine tablets? Terbinafine tablets may cause serious side effects, including: Liver problems that can lead to the need for a liver transplant or death. This can happen in people who have liver problems and in people who have never had liver problems. Tell your doctor right away if you get any of these symptoms of liver problems: • nausea • poor appetite • tiredness • vomiting • upper right stomach-area (abdomen) pain • yellowing of your skin or eyes (jaundice) • dark (tea-colored) urine • pale or light colored stools Your doctor should do a blood test to check you for liver problems before you start treatment with terbinafine tablets. Your doctor may also check you for liver problems during treatment, and tell you to stop taking terbinafine tablets if you develop liver problems. What are terbinafine tablets? Terbinafine tablets are a prescription medicine used to treat fungal infections of the fingernails and toenails (onychomycosis). Your doctor should do tests to check you for fungal infection of your nails before you start terbinafine tablets. It is not known if terbinafine tablets, are safe and effective in children for the treatment of onychomycosis. Who should not take terbinafine tablets? Do not take terbinafine tablets if you: • have had a severe allergic reaction to terbinafine hydrochloride when taken by mouth. • have had liver disease for a long time (chronic) or have active liver disease. What should I tell my doctor before taking terbinafine tablets? Before taking terbinafine tablets, tell your doctor about all of your medical conditions, including if you: • have or had liver problems • have a weakened immune system (immunocompromised) • have lupus (an autoimmune disease) • are pregnant or plan to become pregnant. It is not known if Přečtěte si celý dokument
TERBINAFINE- TERBINAFINE HYDROCHLORIDE TABLET LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TERBINAFINE TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TERBINAFINE TABLETS. TERBINAFINE TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1992 RECENT MAJOR CHANGES Dosage and Administration: Assessment Prior to Initiation (2.1) 8/2016 Contraindications (4) 8/2016 Warnings and Precautions: Hepatotoxicity (5.1) 8/2016 INDICATIONS AND USAGE Terbinafine tablets, are an allylamine antifungal indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). (1) DOSAGE AND ADMINISTRATION Prior to administering, evaluate patients for evidence of chronic or active liver disease. (2.1) Fingernail onychomycosis: One 250 mg tablet, once daily for 6 weeks. (2.2) Toenail onychomycosis: One 250 mg tablet, once daily for 12 weeks. (2.2) DOSAGE FORMS AND STRENGTHS Tablet, 250 mg (3) CONTRAINDICATIONS History of allergic reaction to oral terbinafine because of the risk of anaphylaxis. (4) Chronic or active liver disease. (4) WARNINGS AND PRECAUTIONS Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine. Obtain pretreatment serum transaminases. Prior to initiating treatment and periodically during therapy, assess liver function tests. Discontinue terbinafine tablets if liver injury develops. (5.1) Taste disturbance, including taste loss, has been reported with the use of terbinafine tablets. Taste disturbance can be severe, may be prolonged, or may be permanent. Discontinue terbinafine tablets if taste disturbance occurs. (5.2) Smell disturbance, including loss of smell, has been reported with the use of terbinafine tablets. Smell disturbance may be prolonged, or may be permanent. Discontinue terbinafine tablets if smell disturbance occurs. (5.3) Depressive symptoms have been reported with terbinafine use. Přečtěte si celý dokument